- Marston Linehan, M.D., Discusses the Metabolic Basis of Clear Cell Kidney Carcinoma(4:11)
Dr. Marston Linehan discusses TCGA's characterization of clear cell kidney carcinoma and uncovering the metabolic basis of this disease.
- Peter Laird, Ph.D., Describes Key Findings from the TCGA Study of Stomach Cancer at AACR 2014(14:36)
Dr. Peter Laird provides an overview of findings from TCGA’s comprehensive molecular characterization of gastric adenocarcinoma, including four emerging molecular subtypes.
- Chad Creighton, Ph.D., Reports on TCGA Findings on the Metabolic Basis of Kidney Cancer at AACR 2014(11:09)
Dr. Chad Creighton describes the genetic changes underlying clear cell renal cell carcinoma, particularly how tumor stage and severity correlate with a shift in tumor metabolism.
- Ramaswamy Govindan, M.D., Talks About Novel Genetic Alterations Found in the TCGA Analysis of Lung Cancer at AACR 2014(13:54)
Dr. Ramaswamy Govindan discusses novel mutations discovered in lung adenocarcinoma, which could potentially serve as therapeutic targets.
- Roel Verhaak, Ph.D., Presents the Somatic Genomic Landscape of Glioblastoma at AACR 2014(14:24)
Dr. Roel Verhaak reports on major findings from the genomic characterization of over 500 samples of glioblastoma, expanding the genomic landscape of this cancer type, the first to be studied by TCGA.
- David Haussler, Ph.D., Delivers a Lecture on Cancer Genomics and the Significance of TCGA(14:04)
In this lecture, Dr. David Haussler provides a historical overview of the field of genomics leading up to TCGA, including the Cancer Genomics Hub at the University of California, Santa Cruz, and the TCGA Pan-Cancer initiative.
- Neil Hayes, M.D., M.P.H., Talks about What TCGA Means for the Future of Personalized Care(3:18)
Dr. Neil Hayes speaks about the intersection of scientific research and clinical medicine, and the implications of TCGA for the future of personalized cancer care.
- Neil Hayes, M.D., M.P.H., Summarizes Key Findings from the TCGA Study of Lung Cancer(7:12)
Dr. Neil Hayes provides a summary of important findings from the TCGA marker paper mapping the genetic basis of lung squamous cell carcinoma.
- Vesteinn Thorsson, Ph.D., Reviews Key Findings from the TCGA Study on Colorectal Cancer(4:03)
Dr. Vesteinn Thorsson highlights important findings from the TCGA comprehensive analysis of colorectal cancer.
- David Haussler, Ph.D., and Christopher Benz, M.D., Describe How Genomics Research can Advance Personalized Cancer Care(4:11)
Dr. David Haussler and Dr. Christopher Benz explain how integration of large-scale genomics data in cancer genomics research can accelerate the path to personalized care.
- Peter Laird, Ph.D., Talks about the Transformative Role of Epigenetics in Cancer Research(4:59)
Director of the University of Southern California’s Epigenome Center Dr. Peter Laird highlights important advances in the field of epigenetics and how it is transforming cancer research.
- Gordon Mills, M.D., Ph.D., Discusses Unexpected Therapy Responses in Some Cancer Patients(1:02)
Dr. Gordon Mills provides three examples of therapies that have demonstrated unexpected benefits for some cancer patients.
- Gordon Mills, M.D., Ph.D., Provides an Overview of the Field of Targeted Therapeutics(1:28)
Dr. Gordon Mills discusses early successful targeted cancer therapies like Gleevec and the next steps for creating more effective targeted therapies in the future.
- Timothy Ley, M.D., Advocates for Personalized Medicine in the Treatment of AML(2:41)
Oncologist Dr. Timothy Ley talks about how repurposing of existing drugs based on better understanding of the genetic basis of acute myeloid leukemia (AML) can help patients receive personalized care.
- Paul Spellman, Ph.D., Discusses New Study on Genetics of Ovarian Cancer(2:34)
Computational scientist Dr. Paul Spellman discusses the results of a new TCGA study to genomically characterize ovarian cancer.
- Paul Spellman, Ph.D., Talks about TCGA at AACR 2011(8:50)
Dr. Paul Spellman discusses how TCGA could help advance the treatment of cancer.
- Lynda Chin, M.D., Highlights Important Advances in Cancer Genomics Research, including TCGA, at AACR 2011(6:26)
At the 2011 AACR meeting, Dr. Lynda Chin talks about recent advances in cancer genomics, including the wealth of information that has come from TCGA.
- Charles Perou, Ph.D., Describes the Power of Next-Generation Sequencing Technology in Genomics Research at AACR 2010(5:05)
At the 2010 AACR meeting, Dr. Charles Perou explains how next-generation sequencing technology is transforming cancer genomics research.
- Julie Gastier-Foster, Ph.D., Explains Nationwide Children Hospital’s Role in TCGA(1:48)
Dr. Julie Gastier-Foster discusses Nationwide Children's role as a Biospecimen Core Resource for TCGA.
- Julie Gastier-Foster, Ph.D., Discusses Tissue Collection for TCGA(1:08)
Dr. Julie Gastier-Foster describes the goal of TCGA.
- Julie Gastier-Foster, Ph.D., Anticipates the Future of Personalized Medicine Informed by Findings from TCGA(1:49)
Dr. Julie Gastier-Foster discusses the role TCGA will play in advancing personalized medicine.
- Neil Hayes, M.D., M.P.H., Discusses Personalized Medicine and Lung Cancer Research(5:59)
Dr. Neil Hayes talks about the transition to personalized medicine in lung cancer treatment, new biomarkers, and clinical trials for new targeted therapeutics in lung cancer.
- Cancer Bulletin Profile: In Their Own Words: Raju Kucherlapati, Ph.D.(2:15)
Dr. Raju Kucherlapati, the Paul C. Cabot Professor of Genetics at Harvard Medical School, speaks about cancer genetics and genomics.
- Neil Hayes, M.D., M.P.H., Explains TCGA Findings on Subtypes of Glioblastoma(3:53)
Dr. Neil Hayes reviews TCGA’s finding that glioblastoma comprises four distinct molecular subtypes.
- Stephen Baylin, M.D., Explains Epigenetics(1:14)
Cancer research leader Dr. Stephen Baylin discusses how "things go wrong in cancer" and the role of epigenetics in cancer.
- Stephen Baylin, M.D., Discusses Clinical Implications of TCGA Findings On Glioblastoma(2:51)
Dr. Stephen Baylin discusses the potential clinical implications from decoding the genome of brain cancer, the first cancer type studied by TCGA.
- Stephen Baylin, M.D., Explains the Difference Between Genetics and Epigenetics(1:42)
Dr. Stephen Baylin at the Johns Hopkins Kimmel Cancer Center discusses how alterations in DNA are deciphered by TCGA to decode the brain cancer genome.
- Stephen Baylin, M.D., Explains Why GBM was the First Cancer Type Studied by TCGA(0:42)
Stephen Baylin, M.D. discusses why glioblastoma multiforme (GBM), a deadly brain tumor in adults, was the first cancer chosen for study by TCGA.
More Videos >